[HTML][HTML] Strategies for reducing toxicity and enhancing efficacy of chimeric antigen receptor T cell therapy in hematological malignancies
H Wang, L Tang, Y Kong, W Liu, X Zhu… - International Journal of …, 2023 - mdpi.com
Chimeric antigen receptor T cell (CAR-T) therapy in hematologic malignancies has made
great progress, but there are still some problems. First, T cells from tumor patients show an …
great progress, but there are still some problems. First, T cells from tumor patients show an …
[HTML][HTML] The potential role of the thymus in immunotherapies for acute myeloid leukemia
C Hino, Y Xu, J Xiao, DJ Baylink, ME Reeves… - Frontiers in …, 2023 - frontiersin.org
Understanding the factors which shape T-lymphocyte immunity is critical for the
development and application of future immunotherapeutic strategies in treating …
development and application of future immunotherapeutic strategies in treating …
Recent advances and research progress in biomarkers for chronic graft versus host disease
R Ji, Y Li, R Huang, J Xiong, X Wang… - Critical Reviews in …, 2023 - Elsevier
Chronic graft-versus host disease (cGVHD) is a major risk for patients undergoing
allogeneic hematopoietic stem cell transplantation. With the emergence of novel therapies …
allogeneic hematopoietic stem cell transplantation. With the emergence of novel therapies …